Millennium Management »

Bridgebio Oncology Therapeut shares owned by Millennium Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 266k 8.95
2025-12-31 $3.0M 241k 12.52
2025-09-30 $4.1M 370k 10.98

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
EcoR1 Capital
Alphabet
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Laurion Capital Management
Adage Capital Partners GP
Armistice Capital
Eventide Asset Management
Aisling Capital Management

View all funds holding Bridgebio Oncology Therapeut